First breakthrough in treating asthma attacks and COPD in 50 years hailed as a ‘game-changer’ by doctors
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation